Malaria News and Research

Latest Malaria News and Research

Inovio publishes scientific paper detailing SynCon DNA vaccine preclinical study for prostate cancer

Inovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper in the journal Human Vaccines detailing potent immune responses in a preclinical study of Inovio's SynCon DNA vaccine for prostate cancer targeting two antigens.

2 Feb 2011

Bill Gates' annual letter calls for focus on eradicating polio, governments to sustain foreign aid

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, "urged developed nations to help him wipe out polio 'once and for all' at an event to release his third annual letter [.pdf] Monday," Agence France-Presse reports.

2 Feb 2011

At AU Summit, U.N. Secretary-General calls for more efforts to empower women, stop sexual violence

On the final day of the two-day African Union Summit taking place in Addis Ababa, Ethiopia, U.N. Secretary-General Ban Ki-moon on Monday called for greater efforts to reduce sexual violence, particularly during armed conflicts, Ezega.com reports.

2 Feb 2011

Bill Gates argues the case for polio eradication and expanded childhood immunization

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, argues the case for polio eradication and expanded childhood immunization in his third annual letter released today. The letter, a personal account of his priorities, also calls on governments to invest in foreign aid, even in the face of a tough economic climate.

1 Feb 2011

U.K., Gates Foundation announce extra funding for global polio eradication as WEF wraps up

U.K. Prime Minister David Cameron and Bill Gates, co-chair of the Bill & Melinda Gates Foundation, on Friday at the World Economic Forum (WEF) in Davos, Switzerland, announced "extra financing for polio eradication, easing a shortfall in funding that hinders a global effort to stop the crippling virus," Bloomberg reports.

1 Feb 2011

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Inovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the regulatory approval of a Phase 2 clinical trial to treat leukemia utilizing Inovio's new ELGEN 1000 automated vaccine delivery device.

31 Jan 2011

UK government, Bill & Melinda Gates Foundation to support efforts to stamp out polio

British Prime Minister David Cameron said today that the United Kingdom would double its current contribution to polio eradication.

29 Jan 2011

Recent releases in Global Health

Innovative Health Financing Can Benefit Global Health, Pharma: "The launch of pneumococcal vaccination in Nicaragua under AMC [advance market commitment] has shown that innovative approaches to health financing can benefit both global health and pharmaceutical companies," according to a Lancet Infectious Diseases editorial that describes how the roll-out of GAVI initiative is helping to provide developing countries with low-cost pneumococcal vaccines.

28 Jan 2011

AfrOx and ESMO join to raise international awareness of growing problem of cancer in Africa

To coincide with World Cancer Day 2011, on 4 February, the Africa Oxford Cancer Foundation (AfrOx) and the European Society for Medical Oncology (ESMO) are working together to raise international awareness of the growing problem of cancer in Africa.

28 Jan 2011

Preclinical data on Inovio’s intradermal electroporation delivery devices presented at Phacilitate Vaccine Forum

Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the presentation of recent preclinical data using its next generation of minimally invasive intradermal (skin) electroporation delivery devices at the Phacilitate Vaccine Forum 2011 in Washington, DC.

28 Jan 2011

Inovio to use proceeds from $24.3M offering for development of DNA vaccine against cervical dysplasias

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the closing of the sale to a single institutional investor of 21,130,400 shares of its common stock and warrants to purchase up to 10,565,200 additional shares of its common stock.

28 Jan 2011

Reuters examines how Russia's 'drug problem' has 'become an AIDS problem'

Reuters, in a piece exploring the issue of heroin use in Russia describes how the country's "drug problem has now become an AIDS problem."

28 Jan 2011

Opinions: Global poverty; Global Fund corruption; Tackling poverty, environmental issues

Ahead of the World Economic Forum in Davos, Switzerland, Laurence Chandy and Geoffrey Gert, both of the Brookings Institution's Global Economy and Development program, reflect on "Poverty's Success Story," a Washington Post opinion piece. They note that the last time the World Bank issued global poverty statistics (the number of people in the world living on less than $1.25 each day) was 2005.

28 Jan 2011

AHF surpasses 150,000 patient milestone

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, is proud to announce a major milestone in its mission to provide cutting-edge medicine and advocacy regardless of a person's ability to pay. The organization has recently surpassed the 150,000 patient mark worldwide.

27 Jan 2011

Pfenex receives $3.1 million SAIC sub-contract to develop malaria antigen

Pfenex today announced that Science Applications International Corporation has awarded Pfenex a sub-contract valued at $3.1 million to help develop a robust, scalable, cGMP ready production process for large scale production of full length Circumsporozoite protein from Plasmodium falciparum.

27 Jan 2011

Lancet series examines health issues facing populations in Southeast Asia

"Southeast Asia's 600 million people are facing a raft of new health challenges as the disaster-prone region undergoes some of the world's fastest social change," according to a series of papers and commentary pieces, published Tuesday in the Lancet, Agence France-Presse reports (O'Brien, 1/25).

27 Jan 2011

m2m, HP collaborate to prevent mother-to-child HIV transmission in Africa

Today at the Digital Life Design conference, HP and mothers2mothers (m2m), a South Africa-based nongovernmental organization, announced a new collaboration that will use the power of technology to help prevent the transmission of HIV from HIV-positive pregnant mothers in Africa to their children.

25 Jan 2011

NBC News examines drug-resistant malaria along Thai-Cambodian border

NBC News' "World Blog" reports on the emergence of drug-resistant malaria along the border between Thailand and Cambodia. "The Pailin area [in Cambodia] is now the epicenter of a fight to contain a growing resistance to Artemisinin, which is the world's main anti-malarial drug," the blog writes before noting the global health community's efforts to contain the spread of drug-resistant malaria.

24 Jan 2011

CRI, Oncovir sign new investment agreement to produce immunological stimulant

Cancer Research Institute, a U.S. nonprofit organization founded in 1953 to advance the science of tumor immunology and foster the discovery and development of new cancer immunotherapies, announced today that its Cancer Vaccine Acceleration Fund, a joint initiative with the Ludwig Institute for Cancer Research, has completed a new investment agreement with Oncovir, a biotechnology company based in Washington, D.C., to enable the production of the immunological stimulant Hiltonol- (Poly-ICLC).

24 Jan 2011

CVAF completes new investment agreement with Oncovir for production of Hiltonol

Cancer Research Institute, Inc. (CRI), a U.S. nonprofit organization founded in 1953 to advance the science of tumor immunology and foster the discovery and development of new cancer immunotherapies, announced today that its Cancer Vaccine Acceleration Fund (CVAF), a joint initiative with the Ludwig Institute for Cancer Research (LICR), has completed a new investment agreement with Oncovir, Inc., a biotechnology company based in Washington, D.C., to enable the production of the immunological stimulant Hiltonol® (Poly-ICLC).

21 Jan 2011

Malaria News and Research

Latest Malaria News and Research

Inovio publishes scientific paper detailing SynCon DNA vaccine preclinical study for prostate cancer

Bill Gates' annual letter calls for focus on eradicating polio, governments to sustain foreign aid

At AU Summit, U.N. Secretary-General calls for more efforts to empower women, stop sexual violence

Bill Gates argues the case for polio eradication and expanded childhood immunization

U.K., Gates Foundation announce extra funding for global polio eradication as WEF wraps up

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

UK government, Bill & Melinda Gates Foundation to support efforts to stamp out polio

Recent releases in Global Health

AfrOx and ESMO join to raise international awareness of growing problem of cancer in Africa

Preclinical data on Inovio’s intradermal electroporation delivery devices presented at Phacilitate Vaccine Forum

Inovio to use proceeds from $24.3M offering for development of DNA vaccine against cervical dysplasias

Reuters examines how Russia's 'drug problem' has 'become an AIDS problem'

Opinions: Global poverty; Global Fund corruption; Tackling poverty, environmental issues

AHF surpasses 150,000 patient milestone

Pfenex receives $3.1 million SAIC sub-contract to develop malaria antigen

Lancet series examines health issues facing populations in Southeast Asia

m2m, HP collaborate to prevent mother-to-child HIV transmission in Africa

NBC News examines drug-resistant malaria along Thai-Cambodian border

CRI, Oncovir sign new investment agreement to produce immunological stimulant

CVAF completes new investment agreement with Oncovir for production of Hiltonol

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in